Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
4
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4
×
cancer
cancer immunotherapy
clinical trials
deals
johnson & johnson
startups
abbvie
aduro biotech
agenus
alzheimer's disease
biogen
bristol-myers squibb
What
companies
4
×
drug
4
×
bio
roundup
approval
fda
nash
new
news
price
therapies
year
alzheimer’s
approved
arguments
big
biogen’s
biopharmaceutical
class
commercialized
competitors
convo
decades
different
digital
disease
drugs
earlier
epidemic
fail
failures
fatty
frenzied
gene
growing
increases
known
latest
led
littered
Language
Current search:
companies
×
drug
×
" san diego top stories "
×
" wisconsin top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More